Evidence map›Paper›PMID 12900521›Full record

ArticleThe Journal of experimental medicine2003

The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma.

Christina Nassenstein, Armin Braun, Veit Johannes Erpenbeck, Marek Lommatzsch, Stephanie Schmidt, Norbert Krug, Werner Luttmann, Harald Renz, Johann Christian Virchow

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Neurotrophins: Neuroimmune Interactions in Human Atopic Diseases.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Review
  10. Effect of BDNF on airway inflammation in a rat model of COPD.Experimental and therapeutic medicine · 2021
    Article
  11. Review
  12. Article
  13. Neurotrophin Regulation and Signaling in Airway Smooth Muscle.Advances in experimental medicine and biology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The nasal methylome and childhood atopic asthma.The Journal of allergy and clinical immunology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Christina NassensteinFraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.
Armin Braun
Veit Johannes Erpenbeck
Marek Lommatzsch
Stephanie Schmidt
Norbert Krug
Werner Luttmann
Harald Renz
Johann Christian Virchow
Fraunhofer Institute for Toxicology and Experimental Medicine · DEUniversity of Rostock · DEPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurotrophins (nerve growth factor [NGF], brain-derived neurotrophic factor [BDNF], neurotrophin [NT]-3, and NT-4) have been observed in elevated concentrations in allergic diseases. Neurotrophin levels are up-regulated endobronchially after allergen challenge. This coincides with an influx of activated eosinophils into the bronchial lumen. These eosinophils have an increased viability and CD69 expression 18 h after segmental allergen provocation (SAP) which is not present in peripheral blood. To investigate whether these observations are related we studied the influence of neurotrophins on eosinophil function in allergic asthma. Incubation with NGF, BDNF, NT-3, or NT-4 caused a significant increase in the viability and CD69 expression of isolated eosinophils from bronchoalveolar lavage fluid (BALF) but not from peripheral blood, suggesting a unique sensitivity of endobronchial eosinophils to neurotrophins. To elucidate the underlying mechanisms expression of the neurotrophin receptors p75NTR, trkA, trkB, and trkC on eosinophils was analyzed by RT-PCR and immunocytology. After SAP expression of all neurotrophin receptors was markedly elevated on eosinophils from BALF. Our findings suggest that neurotrophin-mediated activation of bronchial eosinophils might play a role in the regulation of eosinophilic inflammation in allergic asthma.

Indexed as

Bronchial HyperreactivityAdultAntigens, CDAntigens, Differentiation, T-LymphocyteAsthmaBrain-Derived Neurotrophic FactorBronchial Provocation TestsBronchoalveolar Lavage FluidCD69 AntigensEosinophilsFemaleForced Expiratory VolumeHumansLectins, C-TypeMaleNerve Growth FactorAntigens, CDAntigens, Differentiation, T-LymphocyteBrain-Derived Neurotrophic FactorCD69 AntigensLectins, C-TypeNerve Growth FactorNerve Growth FactorsNeuroprotective AgentsNeurotrophin 3neurotrophin 4Receptor, Nerve Growth FactorReceptors, Nerve Growth FactorReceptor, trkAReceptor, trkBReceptor, trkC

Identifiers

PMID12900521
PMCPMC2194097
OpenAlexW2127241705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.